![]() | San Francisco Neurological Society
|
Dinner Meeting Thursday July 16, 2009“Evaluating Patients with Rapidly Progressive Dementia” Hotel Monaco, 501 Geary Street on the corner of Taylor Street, San Francisco, CA 6:15 - 7:00 Registration and Wine Reception Educational Objectives: 1. To identify the main causes of patients with "Rapidly Progressive Dementia" 2. To understand the work-up of a patient with Rapidly Progressive Dementia 3. Expand our knowledge of the prototypical Rapidly Progressive Dementia, Prion Disease or Jakob-Creutzfeldt Disease. Dr. Geschwind received his MD and PhD in neuroscience through the National Institutes of Health-sponsored Medical Scientist Training Program at the Albert Einstein College of Medicine in New York. He completed his internship in internal medicine at the University of California, Los Angeles Medical Center, his neurology residency at the Johns Hopkins University School of Medicine in Baltimore and his fellowship in behavioral neurology at the UCSF Memory and Aging Center (MAC). He joined the Memory and Aging Center faculty in 2003 and is an Associate Professor of Neurology. Dr. Geschwind evaluates patients in the MAC new patient clinic and participates in the management and care for these patients in the MAC continuity clinic. He is active in the training of medical students and residents at UCSF. Dr. Geschwind teaches a national course and lectures, both nationally and internationally, on the assessment of rapidly progressive dementias, including human prion diseases. Dr. Geschwind's primary research interest is the assessment and treatment of rapidly progressive dementias, including prion diseases such as Creutzfeldt-Jakob disease (CJD). Dr. Geschwind helped establish an inpatient hospital program for the assessment of rapidly progressive dementias at UCSF, one of the first of its kind in the country. He ran the first ever US treatment study for CJD. He also has an active research interest in cognitive dysfunction in movement disorders, such as Huntington's disease, corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and other Parkinsonian dementias. Who Should Attend? Neurologists, neurosurgeons, neuroradiologists, residents and other physicians interested in research and clinical advances in the neurosciences. Accreditation Statement Designation Statement Hotel Monaco, 501 Geary Street on the corner of Taylor Street, San Francisco, CA, Telephone: For more information: The San Francisco Neurological Society is an organization of physicians with a dedicated interest in the clinical neurosciences. The Society is committed to the continuing medical education of its members and has an obligation to its members and to the public to provide ongoing educational programs designed to improve patient care and foster scholarly activity in the neurosciences. This obligation includes not only imparting to the membership an increased understanding of neurological diseases through lectures on clinical and basic research, but also making them aware of community and public health issues related to neurological illnesses and preventive medicine. The Society is a CMA-accredited provider. Physicians attending this course may report up to 8 hours of Category 1 credit toward the California Medical Association Certificate in Continuing Medical Education and the American Medical Associations Physicians Recognition Award.
|